Across TCGA pan-cancer cohorts, ST3GAL4 mass-spec protein differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of ST3GAL4’s most consistent transcriptional readouts.
The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where ST3GAL4 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types ST3GAL4 is over-expressed in tumor, although a few such as HNSC and COAD show the opposite, repressed pattern.
HNSC, COAD, and PDAC are the cancer types where ST3GAL4 tumor–normal differential expression is most reproducible.